Titre : Gui

Gui : Questions médicales fréquentes

Termes MeSH sélectionnés :

Exanthema
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Gui : Questions médicales les plus fréquentes", "headline": "Gui : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Gui : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-07-05", "dateModified": "2025-04-01", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Gui" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Magnoliopsida", "url": "https://questionsmedicales.fr/mesh/D019684", "about": { "@type": "MedicalCondition", "name": "Magnoliopsida", "code": { "@type": "MedicalCode", "code": "D019684", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "B01.875.800.575.912.250" } } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Loranthaceae", "alternateName": "Loranthaceae", "url": "https://questionsmedicales.fr/mesh/D028183", "about": { "@type": "MedicalCondition", "name": "Loranthaceae", "code": { "@type": "MedicalCode", "code": "D028183", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "B01.875.800.575.912.250.735.249" } } }, { "@type": "MedicalWebPage", "name": "Viscaceae", "alternateName": "Viscaceae", "url": "https://questionsmedicales.fr/mesh/D028163", "about": { "@type": "MedicalCondition", "name": "Viscaceae", "code": { "@type": "MedicalCode", "code": "D028163", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "B01.875.800.575.912.250.735.888" } } } ], "about": { "@type": "MedicalCondition", "name": "Gui", "alternateName": "Mistletoe", "code": { "@type": "MedicalCode", "code": "D014784", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Jutta Huebner", "url": "https://questionsmedicales.fr/author/Jutta%20Huebner", "affiliation": { "@type": "Organization", "name": "Klinik Für Innere Medizin II, Hämatologie Und Onkologie, Universitätsklinikum Jena, Jena, Germany." } }, { "@type": "Person", "name": "Jin Chen", "url": "https://questionsmedicales.fr/author/Jin%20Chen", "affiliation": { "@type": "Organization", "name": "CAS Key Laboratory of Tropical Forest Ecology, Xishuangbanna Tropical Botanical Garden, Chinese Academy of Sciences, Mengla, 666303, Yunnan, China." } }, { "@type": "Person", "name": "Ling Zhang", "url": "https://questionsmedicales.fr/author/Ling%20Zhang", "affiliation": { "@type": "Organization", "name": "CAS Key Laboratory of Tropical Forest Ecology, Xishuangbanna Tropical Botanical Garden, Chinese Academy of Sciences, Mengla, 666303, Yunnan, China. zhangl@xtbg.org.cn." } }, { "@type": "Person", "name": "David M Watson", "url": "https://questionsmedicales.fr/author/David%20M%20Watson", "affiliation": { "@type": "Organization", "name": "" } }, { "@type": "Person", "name": "Peiying Yang", "url": "https://questionsmedicales.fr/author/Peiying%20Yang", "affiliation": { "@type": "Organization", "name": "Departments of Palliative, Rehabilitation, and Integrative Medicine, The University of Texas MD Anderson Cancer Center, Texas, Houston, USA." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Symmetrical drug-related intertriginous and flexural exanthema (SDRIFE) after administration of corticosteroids: Case series and review of literature.", "datePublished": "2024-05-20", "url": "https://questionsmedicales.fr/article/38769741", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1111/cod.14594" } }, { "@type": "ScholarlyArticle", "name": "Don't rash it! The clinical significance of positive Varicella zoster virus PCR in cerebrospinal fluid of patients with neurological symptoms.", "datePublished": "2024-01-22", "url": "https://questionsmedicales.fr/article/38309173", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.jcv.2024.105648" } }, { "@type": "ScholarlyArticle", "name": "Comparison of cutaneous adverse events between second-generation tyrosine kinase inhibitors and imatinib for chronic myeloid leukemia: a systematic review and meta-analysis.", "datePublished": "2023-11-25", "url": "https://questionsmedicales.fr/article/37787749", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1080/0284186X.2023.2263152" } }, { "@type": "ScholarlyArticle", "name": "Neurosyphilis presenting with Guillain-Barre syndrome: a case report.", "datePublished": "2023-11-25", "url": "https://questionsmedicales.fr/article/38001427", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1186/s12883-023-03471-5" } }, { "@type": "ScholarlyArticle", "name": "Clinical features of dermatomyositis patients with anti-TIF1 antibodies: A case based comprehensive review.", "datePublished": "2023-10-19", "url": "https://questionsmedicales.fr/article/37863375", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.autrev.2023.103464" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Eucaryotes", "item": "https://questionsmedicales.fr/mesh/D056890" }, { "@type": "ListItem", "position": 3, "name": "Viridiplantae", "item": "https://questionsmedicales.fr/mesh/D057948" }, { "@type": "ListItem", "position": 4, "name": "Streptophyta", "item": "https://questionsmedicales.fr/mesh/D057949" }, { "@type": "ListItem", "position": 5, "name": "Embryophyta", "item": "https://questionsmedicales.fr/mesh/D019669" }, { "@type": "ListItem", "position": 6, "name": "Tracheobionta", "item": "https://questionsmedicales.fr/mesh/D064028" }, { "@type": "ListItem", "position": 7, "name": "Magnoliopsida", "item": "https://questionsmedicales.fr/mesh/D019684" }, { "@type": "ListItem", "position": 8, "name": "Gui", "item": "https://questionsmedicales.fr/mesh/D014784" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Gui - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Gui", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-16", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Gui", "description": "Comment diagnostiquer une intoxication au gui ?\nQuels tests sont utilisés pour le gui en médecine ?\nQuels signes cliniques indiquent une réaction au gui ?\nLe gui peut-il être détecté par imagerie ?\nComment différencier le gui des autres plantes ?", "url": "https://questionsmedicales.fr/mesh/D014784?mesh_terms=Exanthema&page=2#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Gui", "description": "Quels sont les symptômes d'une intoxication au gui ?\nLe gui provoque-t-il des allergies ?\nQuels effets secondaires sont associés au gui ?\nLe gui peut-il causer des troubles respiratoires ?\nQuels symptômes sont liés à l'utilisation thérapeutique du gui ?", "url": "https://questionsmedicales.fr/mesh/D014784?mesh_terms=Exanthema&page=2#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Gui", "description": "Comment prévenir l'intoxication au gui ?\nLe gui est-il dangereux pour les animaux ?\nComment identifier le gui dans la nature ?\nQuelles précautions prendre lors de la récolte du gui ?\nLe gui peut-il être cultivé en toute sécurité ?", "url": "https://questionsmedicales.fr/mesh/D014784?mesh_terms=Exanthema&page=2#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Gui", "description": "Comment traiter une intoxication au gui ?\nLe gui est-il utilisé en oncologie ?\nQuels médicaments interagissent avec le gui ?\nLe gui peut-il être utilisé en phytothérapie ?\nQuels sont les traitements alternatifs au gui ?", "url": "https://questionsmedicales.fr/mesh/D014784?mesh_terms=Exanthema&page=2#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Gui", "description": "Quelles complications peuvent survenir avec le gui ?\nLe gui peut-il causer des problèmes cardiaques ?\nQuels sont les risques d'une surconsommation de gui ?\nLe gui peut-il affecter la grossesse ?\nQuelles sont les conséquences d'une réaction allergique au gui ?", "url": "https://questionsmedicales.fr/mesh/D014784?mesh_terms=Exanthema&page=2#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Gui", "description": "Qui est à risque d'intoxication au gui ?\nLes personnes allergiques au gui sont-elles plus à risque ?\nLe risque d'intoxication varie-t-il selon la région ?\nLes personnes âgées sont-elles plus vulnérables au gui ?\nLes utilisateurs de médecines alternatives sont-ils à risque ?", "url": "https://questionsmedicales.fr/mesh/D014784?mesh_terms=Exanthema&page=2#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment diagnostiquer une intoxication au gui ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "L'intoxication se diagnostique par l'examen des symptômes cliniques et l'historique d'exposition." } }, { "@type": "Question", "name": "Quels tests sont utilisés pour le gui en médecine ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Des tests sanguins peuvent être effectués pour évaluer les niveaux de toxines en cas d'intoxication." } }, { "@type": "Question", "name": "Quels signes cliniques indiquent une réaction au gui ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Les signes incluent des nausées, des vomissements, des troubles respiratoires et des convulsions." } }, { "@type": "Question", "name": "Le gui peut-il être détecté par imagerie ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Non, le gui ne peut pas être détecté par imagerie, mais ses effets peuvent l'être indirectement." } }, { "@type": "Question", "name": "Comment différencier le gui des autres plantes ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "Le gui se distingue par ses baies blanches et sa croissance sur d'autres arbres, souvent en hiver." } }, { "@type": "Question", "name": "Quels sont les symptômes d'une intoxication au gui ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes incluent des nausées, des vomissements, des douleurs abdominales et des vertiges." } }, { "@type": "Question", "name": "Le gui provoque-t-il des allergies ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Oui, certaines personnes peuvent développer des réactions allergiques au gui, comme des éruptions cutanées." } }, { "@type": "Question", "name": "Quels effets secondaires sont associés au gui ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Les effets secondaires peuvent inclure des troubles gastro-intestinaux et des effets neurologiques." } }, { "@type": "Question", "name": "Le gui peut-il causer des troubles respiratoires ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Oui, l'ingestion de gui peut entraîner des difficultés respiratoires dans les cas graves." } }, { "@type": "Question", "name": "Quels symptômes sont liés à l'utilisation thérapeutique du gui ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Des effets comme la fatigue, des maux de tête et des troubles digestifs peuvent survenir." } }, { "@type": "Question", "name": "Comment prévenir l'intoxication au gui ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "Évitez de consommer des baies de gui et éduquez-vous sur les plantes toxiques." } }, { "@type": "Question", "name": "Le gui est-il dangereux pour les animaux ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le gui est toxique pour de nombreux animaux, notamment les chiens et les chats." } }, { "@type": "Question", "name": "Comment identifier le gui dans la nature ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Le gui se reconnaît par ses feuilles ovales et ses baies blanches, souvent sur des arbres." } }, { "@type": "Question", "name": "Quelles précautions prendre lors de la récolte du gui ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Portez des gants et évitez le contact direct avec la sève pour prévenir les irritations." } }, { "@type": "Question", "name": "Le gui peut-il être cultivé en toute sécurité ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Oui, mais il faut suivre des pratiques de culture appropriées pour éviter les risques d'intoxication." } }, { "@type": "Question", "name": "Comment traiter une intoxication au gui ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Le traitement inclut l'évacuation du contenu gastrique et des soins symptomatiques en milieu hospitalier." } }, { "@type": "Question", "name": "Le gui est-il utilisé en oncologie ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le gui est parfois utilisé comme traitement complémentaire en oncologie, bien que son efficacité soit débattue." } }, { "@type": "Question", "name": "Quels médicaments interagissent avec le gui ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "Le gui peut interagir avec des anticoagulants et d'autres médicaments, nécessitant une prudence." } }, { "@type": "Question", "name": "Le gui peut-il être utilisé en phytothérapie ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le gui est utilisé en phytothérapie pour ses propriétés supposées, mais avec précaution." } }, { "@type": "Question", "name": "Quels sont les traitements alternatifs au gui ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Des traitements alternatifs incluent des remèdes à base de plantes, mais leur efficacité varie." } }, { "@type": "Question", "name": "Quelles complications peuvent survenir avec le gui ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Les complications incluent des troubles gastro-intestinaux graves et des réactions allergiques sévères." } }, { "@type": "Question", "name": "Le gui peut-il causer des problèmes cardiaques ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Oui, une intoxication sévère au gui peut entraîner des arythmies cardiaques et d'autres problèmes." } }, { "@type": "Question", "name": "Quels sont les risques d'une surconsommation de gui ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Une surconsommation peut entraîner des symptômes graves, y compris des convulsions et un coma." } }, { "@type": "Question", "name": "Le gui peut-il affecter la grossesse ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le gui peut être dangereux pendant la grossesse et doit être évité par précaution." } }, { "@type": "Question", "name": "Quelles sont les conséquences d'une réaction allergique au gui ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Les conséquences peuvent inclure un choc anaphylactique, nécessitant une intervention médicale urgente." } }, { "@type": "Question", "name": "Qui est à risque d'intoxication au gui ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Les enfants et les animaux domestiques sont particulièrement à risque d'intoxication au gui." } }, { "@type": "Question", "name": "Les personnes allergiques au gui sont-elles plus à risque ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les personnes ayant des antécédents d'allergies aux plantes sont plus à risque." } }, { "@type": "Question", "name": "Le risque d'intoxication varie-t-il selon la région ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Oui, certaines régions ont une plus grande prévalence de gui, augmentant le risque d'intoxication." } }, { "@type": "Question", "name": "Les personnes âgées sont-elles plus vulnérables au gui ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les personnes âgées peuvent être plus vulnérables aux effets toxiques du gui." } }, { "@type": "Question", "name": "Les utilisateurs de médecines alternatives sont-ils à risque ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Oui, ceux qui utilisent le gui sans supervision médicale peuvent être à risque d'intoxication." } } ] } ] }

Sources (350 au total)

Symmetrical drug-related intertriginous and flexural exanthema (SDRIFE) after administration of corticosteroids: Case series and review of literature.

Cutaneous manifestations of drug-induced type IV reactions vary widely, with symmetrical drug-related intertriginous and flexural exanthema (SDRIFE) being a less common presentation. Corticosteroids (... The aim of this case series is to report four cases of SDRIFE following systemic prednisolone therapy and to review existing CS classification proposals to better understand cross-reactivity of CS.... Patients recruited at a German dermatology centre underwent allergologic evaluation including prick and patch testing with various CS. Positive cases underwent oral challenge testing with alternative ... Despite a paucity of literature, CS-induced type IV reactions do occur, including SDRIFE. Classification systems based on chemical structure provide insight into cross-reactivity patterns. Provocation... SDRIFE may develop following systemic prednisolone therapy. Classification systems are helpful in understanding cross-reactivity and help in the selection of alternative preparations but are not alway...

Don't rash it! The clinical significance of positive Varicella zoster virus PCR in cerebrospinal fluid of patients with neurological symptoms.

Varicella zoster virus (VZV) is among the leading pathogens causing meningitis and encephalitis. While VZV-PCR-positive CSF is considered a gold-standard for diagnosis, it is not-uncommon to detect VZ... In this retrospective cohort from the largest hospital in Israel, we collected demographic, clinical and laboratory data of patients with VZV-PCR-positive CSF, analyzing the significance of various pa... During a 5-years study, 125 patient-unique VZV-PCR-positive CSFs were recorded, in which only 9 alternative diagnoses were noted. The commonest symptoms were headache (N = 104, 83 %) and rash (N = 96,... Our findings suggest that in patients with neurological symptoms, detection of VZV-DNA in CSF renders VZV the probable culprit. Nevertheless, a systematic evaluation of treatment and follow-up algorit...

Comparison of cutaneous adverse events between second-generation tyrosine kinase inhibitors and imatinib for chronic myeloid leukemia: a systematic review and meta-analysis.

Patients with chronic myeloid leukemia (CML) treated with tyrosine kinase inhibitors (TKIs) often experience cutaneous adverse events, such as rashes and pruritus. In this study, we aimed to compare t... Paired reviewers independently obtained studies from PubMed, Embase, and Cochrane Library published until 15 March 2022. The following terms were searched: (Leukemia, Myelogenous, Chronic and BCR-ABL ... Eleven trials involving 4502 patients were analyzed in this study. Patients treated with second-generation TKIs were significantly more likely to experience cutaneous adverse events than those treated...

Neurosyphilis presenting with Guillain-Barre syndrome: a case report.

Syphilis is associated with a wide variety of systemic presentations, earning it the moniker "The great mimicker". Neurosyphilis is classically associated with meningovasculitis in the acute-subacute ... A 37-year-old female presented to the emergency department with a weakness and difficulty swallowing. She described a three-month history of symptoms, initially starting with a persistent headache fol... This case describes a clinical entity of syphilitic Guillain-Barre Syndrome and highlights the importance of including syphilis in the differential of any patient presenting with ascending polyradicul...

Clinical features of dermatomyositis patients with anti-TIF1 antibodies: A case based comprehensive review.

Dermatomyositis is chronic autoimmune disease primarily affecting skin and muscles. Antibodies are key players of pathogenesis and are in strong correlation with distinct clinical phenotypes. We prese... PubMed and Web of Science databases were reviewed. 166 articles were identified; 95 of them were evaluated; 79 of them included to the study. 45 of the included articles were case reports 9 were case ... 69.6% of the patients with Anti TIF1-γ were female. Prevalence of malignancy was 42.6% among patients with Anti TIF1-γ. Muscle weakness (83%), Gottron sign (82.2%), heliotrope rash (73.7%), nailfold c... Patients with advanced age, male gender, dysphagia, and V-neck rash require strict cancer screening. Patients with advanced age, malignancy, dysphagia, and muscle involvement have poor prognosis and s...

Clinical characteristics and predictors of human mpox outcome during the 2022 outbreak in Nigeria: a cohort study.

Research from sub-Saharan Africa that contributes to our understanding of the 2022 mpox (formerly known as monkeypox) global outbreak is insufficient. Here, we describe the clinical presentation and p... We did a cohort study among laboratory-confirmed and probable mpox cases seen in 22 mpox-treatment centres and outpatient clinics across Nigeria. All individuals with confirmed and probable mpox were ... We enrolled 160 people with mpox from 22 states in Nigeria, including 134 (84%) adults, 114 (71%) males, 46 (29%) females, and 25 (16%) people with HIV. Of the 160 patients, distinct febrile prodrome ... During the 2022 global outbreak, mpox in Nigeria was more severe among those with advanced HIV disease and concomitant varicella zoster virus infection. Proactive screening, management of co-infection... None....